Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions.
暂无分享,去创建一个
Ehud Gazit | E. Gazit | S. Efrat | Shimon Efrat | Yariv Mazor | Yair Porat | Y. Mazor | Y. Porat | Yariv Mazor
[1] G. Cooper,et al. ULTRASTRUCTURAL EVIDENCE THAT APOPTOSIS IS THE MECHANISM BY WHICH HUMAN AMYLIN EVOKES DEATH IN RINm5F PANCREATIC ISLET β‐CELLS , 2001, Cell biology international.
[2] Ehud Gazit,et al. A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Meital Reches,et al. Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin* , 2002, The Journal of Biological Chemistry.
[4] S. Radford,et al. Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes , 1997, Nature.
[5] Meital Reches,et al. Amyloidogenic hexapeptide fragment of medin: homology to functional islet amyloid polypeptide fragments , 2004, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[6] C. Hunter. Arene—Arene Interactions: Electrostatic or Charge Transfer? , 1993 .
[7] J. Fraser Stoddart,et al. π–π INTERACTIONS IN SELF‐ASSEMBLY , 1997 .
[8] C. Dobson. Protein folding and misfolding , 2003, Nature.
[9] Fred E. Cohen,et al. Therapeutic approaches to protein-misfolding diseases , 2003, Nature.
[10] H. Lashuel,et al. New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease. , 2002, The Journal of biological chemistry.
[11] C. Betsholtz,et al. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. , 1989, The New England journal of medicine.
[12] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[13] B. Ahrén,et al. Islet amyloid and type 2 diabetes mellitus. , 2000, The New England journal of medicine.
[14] Susan Jones,et al. Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. , 2003, Journal of molecular biology.
[15] J. Bernhagen,et al. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. , 2000, Journal of molecular biology.
[16] L. Tjernberg,et al. Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.
[17] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[18] Claudio Soto,et al. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.
[19] G A Petsko,et al. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.
[20] E. Gazit,et al. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. , 2003, Biochemistry.
[21] Sharon Gilead,et al. Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. , 2002, Journal of molecular biology.
[22] P. Lansbury,et al. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.
[23] P. Lansbury,et al. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.
[24] L. Rossetti,et al. Functional analysis of a conditionally transformed pancreatic beta-cell line. , 1998, Diabetes.
[25] C. Betsholtz,et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Harroun,et al. Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation , 2001, FEBS letters.
[27] A. Takashima,et al. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.
[28] E. Gazit,et al. Completely different amyloidogenic potential of nearly identical peptide fragments. , 2003, Biopolymers.
[29] James C. Sacchettini,et al. Therapeutic strategies for human amyloid diseases , 2002, Nature Reviews Drug Discovery.
[30] Meital Reches,et al. Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes , 2003, Science.
[31] G. Cooper,et al. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid. , 2003, The Biochemical journal.
[32] A. Kapurniotu,et al. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. , 2001, Biopolymers.
[33] M. Findeis,et al. Modified-peptide inhibitors of amyloid beta-peptide polymerization. , 1999, Biochemistry.
[34] F. Gervasio,et al. Stacking and T-shape competition in aromatic-aromatic amino acid interactions. , 2002, Journal of the American Chemical Society.
[35] Andreas Hoenger,et al. De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Fraser,et al. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. , 2002, Journal of molecular biology.
[37] Ehud Gazit,et al. Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.